|
1
|
Zheng X, Liang P, Zheng Y, Yi P, Liu Q,
Han J, Huang Y, Zhou Y, Guo J and Li L: Clinical significance of
hTERC gene detection in exfoliated cervical epithelial cells for
cervical lesions. Int J Gynecol Cancer. 23:758–790. 2013.
View Article : Google Scholar
|
|
2
|
Schmeink CE, Bekkers RL, Massuger LF and
Melchers WJ: The potential role of self-sampling for high-risk
human papillomavirus detection in cervical cancer screening. Rev
Med Virol. 21:139–153. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J,
Zhu L, Zhang YP, Li H, Gu YS and Liu XZ: Human papillomavirus
infection in Beijing, People's Republic of China: A
population-based study. Br J cancer. 101:1635–1640. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McPhail S, Elliss-Brookes L, Shelton J,
Ives A, Greenslade M, Vernon S, Morris EJ and Richards M: Emergency
presentation of cancer and short-term mortality. Br J Cancer.
109:2027–2034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Ward E and Thun M: Declining
death rates reflect progress against cancer. PLoS One. 5:e95842010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aggarwal P, Batra S, Gandhi G and Zutshi
V: Comparison of Papanicolaou test with visual detection tests in
screening for cervical cancer and developing the optimal strategy
for low resource settings. Int J Gynecol Cancer. 20:862–868. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wentzensen N and Silver MI: Biomarkers for
cervical cancer prevention programs: The long and winding road from
discovery to clinical use. J Low Genit Tract Dis. 20:191–194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Belinson JL, Hu S, Niyazi M, Pretorius RG,
Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ and Qiao YL:
Prevalence of type-specific human papillomavirus in endocervical,
upper and lower vaginal, perineal and vaginal self-collected
specimens: Implications for vaginal self-collection. Int J cancer.
127:1151–1157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Belinson JL, Pretorius RG, Enerson C,
Garcia F, Cruz EP, Belinson SE, García E Yeverino and Brainard J:
The Mexican Cervical Cancer Screening Trial (MECCS): Self-sampling
for human papillomavirus with unaided visual inspection as a
secondary screen. Int J Gynecol Cancer. 19:27–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Agorastos T, Chatzistamatiou K,
Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T and
Constantinidis TC; HERMES study group, : Primary screening for
cervical cancer based on high-risk human papillomavirus (HPV)
detection and HPV 16 and HPV 18 genotyping, in comparison to
cytology. PLoS One. 10:e01197552015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ronco G, Dillner J, Elfström KM, Tunesi S,
Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi
P, et al: Efficacy of HPV-based screening for prevention of
invasive cervical cancer: Follow-up of four European randomised
controlled trials. Lancet. 383:524–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuzick J, Cadman L, Mesher D, Austin J,
Ashdown-Barr L, Ho L, Terry G, Liddle S, Wright C, Lyons D and
Szarewski A: Comparing the performance of six human papillomavirus
tests in a screening population. Br J Cancer. 108:908–913. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bouvard V, Baan R, Straif K, Grosse Y,
Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C,
Galichet L, et al: A review of human carcinogens-Part B: Biological
agents. Lancet Oncol. 10:321–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao C, Li Z, Nayar R, Levi AW, Winkler
BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, et al: Prior
high-risk human papillomavirus testing and Papanicolaou test
results of 70 invasive cervical carcinomas dianosed in 2012:
Results of a retrospective multicenter study. Arch Pathol Lab Med.
139:184–188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wright TC, Stoler MH, Behrens CM, Sharma
A, Zhang G and Wright TL: Primary cervical cancer screening with
human papillomavirus: End of study results from the ATHENA study
using HPV as the first-line screening test. Gynecol Oncol.
136:189–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saslow D, Solomon D, Lawson HW, Killackey
M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur
DC, et al: American Cancer Society, American Society for Colposcopy
and Cervical Pathology, and American Society for Clinical Pathology
screening guidelines for the prevention and early detection of
cervical cancer. Am J Clin Pathol. 137:516–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schiffman M, Boyle S, Raine-Bennett T,
Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C,
Erlich HA, et al: The role of human papillomavirus genotyping in
cervical cancer screening: A large-scale evaluation of the cobas
HPV test. Cancer Epidemiol Biomarkers Prev. 24:1304–1310. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang YZ, Ma JF, Zhao FH, Xiang XE, Ma ZH,
Shi YT, Hu SY and Qiao YL: Three-year follow-up results of visual
inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an
alternative screening method for cervical cancer in rural areas.
Chin J Cancer. 29:4–8. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Council for International Organizations of
Medical Sciences, . International ethical guidelines for biomedical
research involving human subjects. Bull Med Ethics. 1–23. 2002.
|
|
20
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 bethesda system: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stoler MH, Wright TC Jr, Sharma A, Apple
R, Gutekunst K and Wright TL; ATHENA (Addressing THE Need for
Advanced HPV Diagnostics) HPV Study Group, : High-risk human
papillomavirus testing in women with ASC-US cytology: Results from
the ATHENA HPV study. Am J Clin Pathol. 135:468–475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cox JT, Castle PE, Behrens CM, Sharma A,
Wright TC Jr and Cuzick J; Athena HPV Study Group, : Comparison of
cervical cancer screening strategies incorporating different
combinations of cytology, HPV testing, and genotyping for HPV
16/18: Results from the ATHENA HPV study. Am J Obstet Gynecol.
208:184.e1–e184.e11. 2013. View Article : Google Scholar
|
|
23
|
Meijer CJ, Berkhof J, Castle PE, Hesselink
AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, et
al: Guidelines for human papillomavirus DNA test requirements for
primary cervical cancer screening in women 30 years and older. Int
J Cancer. 124:516–520. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Söderlund-Strand A, Rymark P, Andersson P,
Dillner J and Dillner L: Comparison between the Hybrid Capture II
test and a PCR-based human papillomavirus detection method for
diagnosis and posttreatment follow-up of cervical intraepithelial
neoplasia. J Clin Microbiol. 43:3260–3266. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saslow D, Solomon D, Lawson HW, Killackey
M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur
DC, et al: American Cancer Society, American Society for Colposcopy
and Cervical Pathology and American Society for Clinical Pathology
screening guidelines for the prevention and early detection of
cervical cancer. Am J Clin Pathol. 137:516–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siddiqa A, Zainab M, Qadri I, Bhatti MF
and Parish JL: Prevalence and genotyping of high risk human
papillomavirus in cervical cancer samples from Punjab, Pakistan.
Viruses. 6:2762–2777. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cuzick J, Arbyn M, Sankaranarayanan R, Tsu
V, Ronco G, Mayrand MH, Dillner J and Meijer CJ: Overview of human
papillomavirus-based and other novel options for cervical cancer
screening in developed and developing countries. Vaccine. 26 Suppl
10:K29–K41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gage JC, Schiffman M, Katki HA, Castle PE,
Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC and
Kinney WK: Reassurance against future risk of precancer and cancer
conferred by a negative human papillomavirus test. J Natl Cancer
Inst. 106:pii: dju1532014. View Article : Google Scholar
|
|
29
|
Srodon M, Dilworth H Parry and Ronnett BM:
Atypical squamous cells, cannot exclude high-grade squamous
intraepithelial lesion: Diagnostic performance, human
papillomavirus testing, and follow-up results. Cancer. 108:32–38.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Crowe E, Pandeya N, Brotherton JM, Dobson
AJ, Kisely S, Lambert SB and Whiteman DC: Effectiveness of
quadrivalent human papillomavirus vaccine for the prevention of
cervical abnormalities: Case-control study nested within a
population based screening programme in Australia. BMJ.
348:g14582014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Massad LS, Einstein MH, Huh WK, Katki HA,
Kinney WK, Schiffman M, Solomon D, Wentzensen N and Lawson HW:
2012; ASCCP Consensus Guidelines Conference: 2012 updated consensus
guidelines for the management of abnormal cervical cancer screening
tests and cancer precursors. 121:pp. 1–846, 2013.
|
|
32
|
Kitchener HC, Almonte M, Thomson C,
Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C,
Dowie R, et al: HPV testing in combination with liquid-based
cytology in primary cervical screening (ARTISTIC): A randomised
controlled trial. Lancet Oncol. 10:672–682. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Strander B, Hällgren J and Sparén P:
Effect of ageing on cervical or vaginal cancer in Swedish women
previously treated for cervical intraepithelial neoplasia grade 3:
Population based cohort study of long term incidence and mortality.
BMJ. 348:f73612014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu Y, Qian HZ, Sun J, Gao L, Yin L, Li X,
Xiao D, Li D, Sun X, Ruan Y, et al: Anal human papillomavirus
infection among HIV-infected and uninfected men who have sex with
men in Beijing, China. J Acquir Immune Defic Syndr. 64:103–114.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ogilvie GS, van Niekerk DJ, Krajden M,
Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook
DA, et al: A randomized controlled trial of Human Papillomavirus
(HPV) testing for cervical cancer screening: Trial design and
preliminary results (HPV FOCAL Trial). BMC Cancer. 10:1112010.
View Article : Google Scholar : PubMed/NCBI
|
